tuberculosis

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Pathology

a human-like protein kinase G renders mycobacteria resistant to bactericidal activity of macrophages, probably by inhibiting fusion of phagosomes with lysosomes[10]

Genetics

Clinical manifestations

Laboratory

Diagnostic procedures

Radiology

Complications

Differential diagnosis

Management

More general terms

More specific terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995
  2. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 183-86
  3. 3.0 3.1 American Thoracic Society: Am J Crit Care Med 149:1359-1374 1994
  4. 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 4.27 4.28 4.29 4.30 4.31 4.32 4.33 4.34 4.35 4.36 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  5. Prescriber's Letter 7(7):40 2000
  6. Journal Watch 20(19):153, 2000
  7. Davies P. Tuberculosis in the elderly. Epidemiology and optimal management. Drugs Aging, 8:436, 1996 PMID: https://www.ncbi.nlm.nih.gov/pubmed/8736627
  8. 8.0 8.1 Journal Watch 21(19):155, 2001 Centers for Disease Control and Prevention (CDC). Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations
    United States, 2001. MMWR Morb Mort Wkly Rep 50:733, 2001 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11787580
  9. 9.0 9.1 9.2 Journal Watch 24(8):64, 2004 Centers for Disease Control and Prevention (CDC). Trends in Tuberculosis - United States 1998-2003, MMWR Morb Mort Wkly Rep 52:209, 2004 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/15029114 <Internet> http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5310a2.htm
  10. 10.0 10.1 Journal Watch 24(13):107, 2004 Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K, Klebl B, Thompson C, Bacher G, Pieters J. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science. 2004 Jun 18;304(5678):1800-4. Epub 2004 May 20. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15155913
  11. 11.0 11.1 Journal Watch 25(4):31-32, 2005 Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2005 Jan 14;307(5707):223-7. Epub 2004 Dec 09. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15591164
  12. 12.0 12.1 Journal Watch 25(15):121, 2005 Geng E, Kreiswirth B, Burzynski J, Schluger NW. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA. 2005 Jun 8;293(22):2740-5. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15941803
  13. 13.0 13.1 Veterans Administration, Mather CA
  14. Controlling Tuberculosis in the United States Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America MMWR: Recommendations and Reports November 4, 2005 / 54(RR12);1-81 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5412a1.htm
    Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005 Dec 30;54(17):1-141. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16382216
  15. 15.0 15.1 Breen RAM et al, Virological response to highly active antiretroviral therapy is unaffected by tuberculosis therapy. J Infect Dis 2006; 193:1437 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16619192
  16. Liu Y et al Overseas screening for tuberculosis in U.S.-bound immigrants and refugees. N Engl J Med 2009 Jun 4; 360:2406. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19494216
  17. 17.0 17.1 Shang S et al. Cigarette smoke increases susceptibility to tuberculosis - Evidence from in vivo and in vitro models. J Infect Dis 2011 May 1; 203:1240 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21357942
  18. Recommendations and Reports Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC MMWR July 7, 2006 July 7, 2006 / 55(RR09);1-44 Corresponding NGC guideline withdrawn Dec 2011 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5509a1.htm
  19. 19.0 19.1 Centers for Disease Control and Prevention Trends in Tuberculosis - United States, 2011 MMWR March 23, 2012 / 61(11);181-185 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6111a2.htm
  20. 20.0 20.1 ARUP Consult: Mycobacterium tuberculosis - TB The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/mycobacterium-tuberculosis
  21. 21.0 21.1 Lee M et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 2012 Oct 18; 367:1508 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23075177
  22. 22.0 22.1 22.2 American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12836625
  23. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010 Sep;10(9):621-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20797644
  24. 24.0 24.1 World Health Oragnization (WHO). 2013 The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. Interim Policy Guideline. http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf
    World Health Oragnization (WHO). 2013 WHO interim guidance on the use of bedaquiline to treat MDR-TB https://mail.google.com/mail/u/0/?shva=1#inbox/13f425db09d8dfc1
  25. World Heath Organization Global tuberculosis report 2013 http://www.who.int/tb/publications/global_report/en/index.html
  26. 26.0 26.1 Anderson ST et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014 May 1; 370:1712 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24785206 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1303657
  27. 27.0 27.1 Gillespie SH et al Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis. N Engl J Med 2014; 371:1577-1587. October 23, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25196020 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1407426
    Merle CS et al A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis. N Engl J Med 2014; 371:1588-1598. October 23, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25337748 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1315817
    Jindani A et al High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis. N Engl J Med 2014; 371:1599-1608. October 23, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25337749 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1314210
    Warner DF, Mizrahi V. Shortening Treatment for Tuberculosis - Back to Basics. N Engl J Med 2014; 371:1642-1643. October 23, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25337754 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1410977
  28. World Health Organiziation (WHO). Oct 22, 2014 Improved data reveals higher global burden of tuberculosis. http://www.who.int/mediacentre/news/notes/2014/global-tuberculosis-report/en/
  29. 29.0 29.1 Levine AC, Shetty PP, Henwood PC, Sabeti P, Katz JT, Vaidya A. Interactive medical case. A Liberian health care worker with fever. N Engl J Med. 2015 Jan 29;372(5):e7. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25629759 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMimc1414101
  30. 30.0 30.1 30.2 30.3 30.4 Scott C et al Tuberculosis Trends - United States, 2014. MMWR Weekly. March 20, 2015 / 64(10);265-269 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6410a2.htm
  31. 31.0 31.1 Orciari Herman A, Sadough S, Sofair A Guidelines Issued on Isolation Precautions for Hospital Visitors; Utility of Face Masks Reviewed Physician's First Watch, April 13, 2015 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    Munoz-Price LS et al Isolation Precautions for Visitors. Infection Control & Hospital Epidemiology. April 10, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26017347 <Internet> http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=9641478&fileId=S0899823X15000677
  32. 32.0 32.1 Centers for Disease Control and Prevention (CDC). Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013. MMWR Morb Mortal Wkly Rep. 2013 Oct 18;62(41):821-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24141407 Free full text
  33. 33.0 33.1 Rowland R, McShane H. Tuberculosis vaccines in clinical trials. Expert Rev Vaccines. 2011 May;10(5):645-58. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21604985 Free PMC Article
  34. Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep. 2006 Jul 7;55(RR-9):1-44. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16826161 Free full text
  35. Nahid P, Dorman SE, Alipanah N et al Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. (2016) Aug 10. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27516382 <Internet> http://cid.oxfordjournals.org/content/early/2016/07/20/cid.ciw376
  36. 36.0 36.1 36.2 36.3 36.4 36.5 36.6 36.7 Lewinsohn DM, Leonard MK, LoBue PA et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: Diagnosis of tuberculosis in adults and children. Clin Infect Dis 2016 Dec 8 http://cid.oxfordjournals.org/content/early/2016/12/08/cid.ciw694
  37. 37.0 37.1 Liu C, Zhao Z, Fan J et al. Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. Proc Natl Acad Sci U S A 2017 Apr 11; 114:3969 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28348223 Free PMC Article <Internet> http://www.pnas.org/content/114/15/3969
  38. Lewinsohn DM, Leonard MK, LoBue PA et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017 Jan 15; 64:e1 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27932390
  39. 39.0 39.1 39.2 39.3 Stewart RJ, Tsang CA, Pratt RH, Price SF, Langer AJ. Tuberculosis - United States, 2017. MMWR Morb Mortal Wkly Rep 2018;67:317-323 https://www.cdc.gov/mmwr/volumes/67/wr/mm6711a2.htm
  40. 40.0 40.1 McBride JA, Lepak AJ, Dhaliwal G The Wrong Frame of Mind. N Engl J Med 2018; 378:1716-1721 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29719187 https://www.nejm.org/doi/full/10.1056/NEJMcps1710814
  41. 41.0 41.1 Chaisson LH, Duong D, Cattamanchi A et al Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital. JAMA Intern Med. Published online August 27, 2018. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30178007 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2697838
    Salfinger M. Molecular Assay Testing to Rule Out Tuberculosis - Be That Early Adopter. JAMA Intern Med. Published online August 27, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30178040 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2697836
  42. Nahid P, Dorman SE, Alipanah NNahid P et al Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 Oct 1;63(7):853-67. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27621353
  43. Lewinsohn DM, Leonard MK, LoBue PA et al Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017 Jan 15;64(2):111-115. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28052967 Free PMC Article
  44. Centers for Disease Control and Prevention TB Guidelines http://www.cdc.gov/tb/publications/guidelines/Treatment.htm
  45. 45.0 45.1 45.2 Light RW Update on tuberculous pleural effusion. Respirology. 2010 Apr;15(3):451-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20345583
  46. 46.0 46.1 46.2 NEJM Knowledge+ Question of the Week. June 23, 2020 https://knowledgeplus.nejm.org/question-of-week/566/
    Zhou Q et al. Diagnostic accuracy of T-cell interferon-gamma release assays in tuberculous pleurisy: a meta-analysis. Respirology 2011 Feb 9; 16:473 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21299686
    Keng LT et al. Evaluating pleural ADA, ADA2, IFN-gamma and IGRA for diagnosing tuberculous pleurisy. J Infect 2013 Jun 26; 67:294 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23796864
  47. Deutsch-Feldman M, Pratt RH, Price SF, Tsang CA, Self JL. Tuberculosis - United States, 2020. MMWR Morb Mortal Wkly Rep 2021;70:409-414 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33764959 https://www.cdc.gov/mmwr/volumes/70/wr/mm7012a1.htm
  48. 48.0 48.1 Dorman SE, Nahid P, Kurbatova EV et al Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med 2021; 384:1705-1718. May 6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33951360 https://www.nejm.org/doi/full/10.1056/NEJMoa2033400
  49. 49.0 49.1 Godfrey MS, Friedman LN Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-alpha and Beyond. Clin Chest Med. 2019 Dec;40(4):721-739 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31731980
  50. 50.0 50.1 Jacobson KR Tuberculosis. Ann Intern Med. 2017 Feb 7;166(3):ITC17-ITC32 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28166561
  51. 51.0 51.1 Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013 Feb 21;368(8):745-55 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23425167 Review. https://www.nejm.org/doi/pdf/10.1056/NEJMra1200894
  52. Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-598 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31548730 Review.
  53. Jacob JT, Nguyen TM, Ray SM. Male genital tuberculosis. Lancet Infect Dis. 2008 May;8(5):335-42. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18471778

Patient information

tuberculosis patient information

Database